This study investigated the circulation of Crimean-Congo hemorrhagic fever virus (CCHFV) among livestock and ixodid ticks in the Karaganda and Ulytau regions of Central Kazakhstan and characterized the detected viral isolate. A targeted cross-sectional surveillance study was conducted during the spring–summer period of 2025 in the Shet, Aktogay, Ulytau, and Zhanaarka districts, as well as in the cities of Zhezkazgan, Satpayev, and Karazhal, selected because of pasture-based livestock management, livestock movement routes, and ecological suitability for ixodid tick populations. In total, 700 whole blood and 700 serum samples were collected from cattle and small ruminants. Additionally, 127 ticks were collected by flagging, direct removal from animals, and manual sampling and were identified morphologically. CCHFV RNA was detected using RT-qPCR, while anti-CCHFV IgG antibodies were detected by ELISA. Virus isolation was performed in BHK-21/13, Vero, CV-1, and MARC-145 cell lines. Viral RNA was not detected in livestock blood samples; however, one of eight tick pools collected in the Mibulak rural district tested positive by RT-qPCR. Anti-CCHFV IgG antibodies were detected in eight serum samples, including four originating from the same locality. A pronounced cytopathic effect was observed in BHK-21/13 and Vero cells on days 4–5 post-infection. Phylogenetic analysis of the S segment demonstrated that isolate CCHF/2025/Mibulak/KZ belongs to the Asia-2 genotype and clusters with strains previously reported from China, Kazakhstan, and Uzbekistan. Taken together, these findings support evidence of localized CCHFV circulation in Central Kazakhstan and highlight the importance of sustained integrated One Health surveillance for early detection and prevention of human infection.
In recent years, mpox has emerged as a significant global public health threat. The widespread distribution of the virus, coupled with the legacy of historical smallpox vaccination, has underscored the critical need to serologically distinguish between natural mpox infection and vaccine-induced humoral immune responses. However, the high antigenic similarity among Orthopoxvirus species leads to the production of cross-reactive antibodies, limiting the differentiation capacity of conventional serological assays. This mini-review evaluates current serological approaches aimed at discriminating between mpox infection and vaccine-induced immunity. Specifically, we analyze multiplexed immunoassays, comparative ratios based on orthologous antigens, machine learning-supported serological models, peptide-based platforms, and recombinant protein-based enzyme-linked immunosorbent assay (ELISA) methods. The findings of this review indicate that multiplex immunoassays, orthologous antigen ratio-based approaches, and machine learning algorithms exhibit the highest discriminatory potential for distinguishing natural mpox infection from vaccine-induced immune responses. In addition, MPXV A27L and ATI-N-CPXV antigens may be considered promising candidates for serological differentiation, although their performance requires further investigation.